 |
市場調查報告書
商品編碼
1544540
糖尿病照護市場的臨床營養、機會、成長動力、產業趨勢分析與預測，2024-2032Clinical Nutrition for Diabetes Care Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032 |
||||||
由於全球糖尿病盛行率上升以及人們日益認知到飲食在控制病情方面的關鍵作用，糖尿病護理臨床營養市場規模預計在 2024 年至 2032 年期間複合年成長率為 4.8%。根據世界衛生組織的數據，全球約有 4.22 億人患有糖尿病。專為糖尿病照護設計的臨床營養產品，例如低血糖指數食品、富含纖維的補充劑和營養豐富的代餐，有助於控制血糖水平並改善整體健康。
產品配方的進步以及根據個人代謝狀況和健康狀況制定量身定做的營養計劃，正在增強飲食干預在糖尿病管理中的功效。因此，醫療保健專業人員和營養師擴大將這些專門的營養產品整合到整體糖尿病護理計劃中，從而推動了市場需求。
整個產業分為產品、疾病類型、消費者、劑型、配銷通路和地區。
從產品來看，腸外營養領域的糖尿病照護臨床營養市場規模預計到 2032 年將產生可觀的收入。腸外營養提供了一種細緻的營養管理方法，包括血糖管理解決方案，對於患有嚴重糖尿病或胃腸道挑戰的個體尤其有益。
就劑型而言，液體領域的糖尿病護理臨床營養市場預計將在2024 年至2032 年期間出現強勁的複合年成長率。方案專為糖尿病患者量身訂做。代餐和治療飲料等產品旨在提供均衡的營養和受調節的碳水化合物含量，有助於有效的血糖管理。
亞太地區糖尿病臨床營養護理行業規模將在 2024 年至 2032 年間大幅成長。隨著中國、印度和日本等國家的糖尿病發病率不斷上升，對有效的臨床營養解決方案的需求不斷增加。
目錄
第 1 章：方法與範圍
第 2 章：執行摘要
第 3 章：產業洞察
- 產業生態系統分析
- 產業影響力
- 成長動力
- 糖尿病盛行率增加
- 臨床營養學的進展
- 老年人口不斷增加
- 產業陷阱與挑戰
- 發展中經濟體的認知有限
- 成長動力
- 成長潛力分析
- 監管環境
- 波特的分析
- PESTEL分析
第 4 章：競爭格局
- 介紹
- 公司矩陣分析
- 公司市佔率分析
- 競爭定位矩陣
- 戰略儀表板
第 5 章：市場估計與預測：按產品分類，2021 - 2032 年
- 主要趨勢
- 口服營養
- 尚未準備好使用
- 即用型
- 液體
- 固體
- 腸外營養
- 常量營養素
- 碳水化合物
- 胺基酸
- 脂質
- 微量營養素
- 維生素
- 礦物質
- 常量營養素
- 腸內餵食配方
- 標準成分
- 疾病具體成分
第 6 章：市場估計與預測：按疾病類型，2021 - 2032 年
- 主要趨勢
- 2型糖尿病
- 1 型糖尿病
第 7 章：市場估計與預測：按消費者分類，2021 - 2032 年
- 主要趨勢
- 成人
- 兒科
第 8 章：市場估計與預測：按劑型，2021 - 2032
- 主要趨勢
- 粉末
- 液體
- 堅硬的
第 9 章：市場估計與預測：按配銷通路分類，2021 - 2032 年
- 主要趨勢
- 零售藥局
- 醫院藥房
- 網路藥局
- 其他分銷管道
第 10 章：市場估計與預測：按地區，2021 - 2032
- 主要趨勢
- 北美洲
- 美國
- 加拿大
- 歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
- 亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
- 拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地區
- 中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區
第 11 章：公司簡介
- Abbott Laboratories
- Baxter International Inc.
- B Braun Melsungen AG
- Danone Nutricia
- Dr Reddy's Laboratories Ltd.
- Mead Johnson and Company, LLC
- Nestle Health Science S.A.
- Nutrego
- Otsuka Holdings Co., Ltd.
- Pfizer Inc.
- Prohance
- Victus, Inc.
Clinical nutrition for diabetes care market size is set to record a 4.8% CAGR during 2024-2032 driven by the global rise in diabetes prevalence and the growing acknowledgment of the pivotal role of diets in managing the condition. As per WHO, around 422 million people have diabetes globally. Clinical nutrition products designed specifically for diabetes care, such as low glycemic index foods, fiber-rich supplements, and nutrient-enriched meal replacements, help manage blood glucose levels and improve overall health.
Advancements in product formulations and the creation of tailored nutritional plans, aligned with individual metabolic profiles and health conditions, are amplifying the efficacy of dietary interventions in diabetes management. As a result, healthcare professionals and dietitians are increasingly integrating these specialized nutrition products into holistic diabetes care plans, driving up market demand.
The overall industry is classified into product, disease type, consumer, dosage form, distribution channel, and region.
Based on product, the clinical nutrition for diabetes care market size from the parenteral nutrition segment is expected to generate notable revenue by 2032. This is due to its ability to provide crucial nutritional support for patients unable to meet dietary needs through oral means. Parenteral nutrition offers a meticulous approach to nutrient administration, including solutions for glucose management, especially beneficial for individuals grappling with severe diabetes or gastrointestinal challenges.
With respect to dosage form, the clinical nutrition for diabetes care market from the liquid segment is projected to observe a robust CAGR during 2024 - 2032. This growth is attributed to the convenience and digestibility of liquid nutritional solutions, which are specifically tailored for diabetic patients. Products like meal replacements and therapeutic beverages are crafted to deliver balanced nutrition with regulated carbohydrate content, aiding in effective blood glucose management.
Asia Pacific the clinical nutrition for diabetes care industry size will grow substantially between 2024 and 2032. This surge is linked to the region's rising diabetes prevalence, heightened healthcare awareness, and better access to specialized nutrition products. With countries like China, India, and Japan witnessing escalating diabetes rates, there is an amplified demand for effective clinical nutrition solutions.
Table of Contents
Chapter 1 Methodology and Scope
- 1.1 Market scope and definitions
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
- 1.4 Forecast model
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources
Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Increasing prevalence of diabetes
- 3.2.1.2 Advancements in clinical nutrition
- 3.2.1.3 Growing geriatric population
- 3.2.2 Industry pitfalls and challenges
- 3.2.2.1 Limited awareness in developing economies
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape
- 3.5 Porter's analysis
- 3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company matrix analysis
- 4.3 Company market share analysis
- 4.4 Competitive positioning matrix
- 4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)
- 5.1 Key trends
- 5.2 Oral nutrition
- 5.2.1 Not ready-to-use
- 5.2.2 Ready-to-use
- 5.2.2.1 Liquids
- 5.2.2.2 Solids
- 5.3 Parenteral nutrition
- 5.3.1 Macronutrients
- 5.3.1.1 Carbohydrates
- 5.3.1.2 Amino acids
- 5.3.1.3 Lipids
- 5.3.2 Micronutrients
- 5.3.2.1 Vitamins
- 5.3.2.2 Minerals
- 5.3.1 Macronutrients
- 5.4 Enteral feeding formulas
- 5.4.1 Standard composition
- 5.4.2 Disease specific composition
Chapter 6 Market Estimates and Forecast, By Disease Type, 2021 - 2032 ($ Mn)
- 6.1 Key trends
- 6.2 Type 2 diabetes
- 6.3 Type 1 diabetes
Chapter 7 Market Estimates and Forecast, By Consumer, 2021 - 2032 ($ Mn)
- 7.1 Key trends
- 7.2 Adult
- 7.3 Pediatric
Chapter 8 Market Estimates and Forecast, By Dosage Form, 2021 - 2032 ($ Mn)
- 8.1 Key trends
- 8.2 Powder
- 8.3 Liquid
- 8.4 Solid
Chapter 9 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)
- 9.1 Key trends
- 9.2 Retail pharmacies
- 9.3 Hospital pharmacies
- 9.4 Online pharmacies
- 9.5 Other distribution channels
Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)
- 10.1 Key trends
- 10.2 North America
- 10.2.1 U.S.
- 10.2.2 Canada
- 10.3 Europe
- 10.3.1 Germany
- 10.3.2 UK
- 10.3.3 France
- 10.3.4 Spain
- 10.3.5 Italy
- 10.3.6 Netherlands
- 10.3.7 Rest of Europe
- 10.4 Asia Pacific
- 10.4.1 China
- 10.4.2 Japan
- 10.4.3 India
- 10.4.4 Australia
- 10.4.5 South Korea
- 10.4.6 Rest of Asia Pacific
- 10.5 Latin America
- 10.5.1 Brazil
- 10.5.2 Mexico
- 10.5.3 Rest of Latin America
- 10.6 Middle East and Africa
- 10.6.1 South Africa
- 10.6.2 Saudi Arabia
- 10.6.3 UAE
- 10.6.4 Rest of Middle East and Africa
Chapter 11 Company Profiles
- 11.1 Abbott Laboratories
- 11.2 Baxter International Inc.
- 11.3 B Braun Melsungen AG
- 11.4 Danone Nutricia
- 11.5 Dr Reddy's Laboratories Ltd.
- 11.6 Mead Johnson and Company, LLC
- 11.7 Nestle Health Science S.A.
- 11.8 Nutrego
- 11.9 Otsuka Holdings Co., Ltd.
- 11.10 Pfizer Inc.
- 11.11 Prohance
- 11.12 Victus, Inc.
